The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Standard-dose pembrolizumab (pembro) plus alternate-dose ipilimumab (ipi) in advanced melanoma: Initial analysis of KEYNOTE-029 cohort 1C.
 
Georgina V. Long
Honoraria - Bristol-Myers Squibb; Merck; Pierre Fabre
Consulting or Advisory Role - Aduro Biotech; Array BioPharma; Bristol-Myers Squibb; Incyte; MERCK; Novartis; OncoSec; Pierre Fabre
Research Funding - BMS Brazil (Inst); Merck (Inst)
 
Caroline Robert
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck; Merck Serono; Novartis; Pierre Fabre; Roche
 
Marcus O. Butler
Honoraria - Bristol-Myers Squibb; Merck; Novartis; Roche
Consulting or Advisory Role - Adaptimmune; Bristol-Myers Squibb; EMD Serono; Genzyme; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Immunocore; Immunovaccine; Merck; Novartis
Research Funding - Merck; Takara Bio
Expert Testimony - Merck
 
Felix Couture
Consulting or Advisory Role - Bristol-Myers Squibb
 
Matteo S. Carlino
Honoraria - Bristol-Myers Squibb; MSD; Novartis
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
 
Steven O'Day
Honoraria - Agenus; Biothera; Bristol-Myers Squibb; ImaginAb; Merck; RadImmune
Consulting or Advisory Role - Agenus; Biothera; Bristol-Myers Squibb; ImaginAb; Merck; RadImmune
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Amgen (Inst); Biothera (Inst); Exicure (Inst); Genocea Biosciences (Inst); Incyte (Inst); Merck (Inst); Oncotherapeutics (Inst); Ultimovacs (Inst); Viralytics (Inst)
Travel, Accommodations, Expenses - Agenus; Bristol-Myers Squibb; Caris MPI; ImaginAb; Merck
 
Victoria Atkinson
Honoraria - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche/Genentech
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche
Speakers' Bureau - Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Roche/Genentech
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme; OncoSec
 
Jonathan S. Cebon
Honoraria - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Novartis
Consulting or Advisory Role - Amgen (Inst); Bionomics; Bionomics (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Novartis; Novartis (Inst)
Research Funding - CSL Behring (Inst); GlaxoSmithKline (Inst)
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline
Expert Testimony - Bristol-Myers Squibb
 
Michael Paul Brown
Consulting or Advisory Role - Amgen (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Roche (Inst)
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pharmaust (Inst); Roche (Inst); Zucero Therapeutics (Inst)
 
Stéphane Dalle
Employment - Sanofi Pasteur (I)
Stock and Other Ownership Interests - Sanofi Pasteur (I)
Consulting or Advisory Role - MSD (Inst)
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Andrew Graham Hill
Employment - Tasman Oncology
Stock and Other Ownership Interests - Tasman Oncology
Honoraria - Bristol-Myers Squibb; Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck
 
Geoffrey Thomas Gibney
Consulting or Advisory Role - Genentech/Roche; Genentech/Roche; Incyte; Newlink Genetics; Newlink Genetics; Novartis; Novartis; Novartis
Speakers' Bureau - Genentech/Roche; Merck
 
Steven L. McCune
Research Funding - Roche/Genentech
 
Alexander M. Menzies
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Novartis; Pierre Fabre; Roche
 
Cuizhen Niu
Employment - MSD
 
Nageatte Ibrahim
Employment - Merck
Stock and Other Ownership Interests - GlaxoSmithKline; Merck
 
Blanca Homet Moreno
Employment - Merck Sharp & Dohme
 
Adi Diab
Consulting or Advisory Role - Celgene; CureVac; Nektar
Research Funding - Celgene (Inst); Idera (Inst); Nektar (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Nektar